Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04527822
Other study ID # 101271-2
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date August 1, 2020
Est. completion date June 1, 2024

Study information

Verified date March 2024
Source University of Jordan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study is utilizing a nurse led discharge program based on the Re-Engineered Discharge program (Project-RED) ( Agency of Healthcare Research and Quality [AHRQ], 2013) which is a package of services designed to minimize discharge failures and minimize re-admissions, reduce mortality, morbidity, complication and improve patients outcomes. Project-RED aims to reduce hospital re-admissions through a series of structured steps led by a nurse called discharge advocate. The intervention will be used to discharge patients post Coronary artery bypass graft surgery.


Description:

Cardiovascular diseases (CVD) are the main threats to human lives (Benjamin et al., 2018). Around 17.9 million deaths worldwide were attributed to CVD (Benjamin et al., 2018); Which Represents 31 % of the global deaths (Benjamin et al., 2018). Coronary artery disease is one of the CVD. Coronary artery disease prevalence among United State (US) adults aged 20 years and above is 6.3 %. It is responsible for 43.8 % of the deaths worldwide. (Benjamin et al., 2018). In Jordan, CVD is the leading cause of death. During 2016; 37 % of all deaths among Jordanian population were due to CVD. Coronary Artery Disease is responsible for 18 % of the deaths (Centers of Disease Control [CDC], 2016) Coronary artery diseases currently are managed with medical treatment, percutaneous coronary interventions (PCI) or Coronary artery bypass graft (CABG) surgery (Habib et al., 2015). Coronary artery bypass graft surgery is the indicated choice for multi-vessel coronary disease (Habib et al., 2015). It is defined as a revascularization procedure used for the treatment of CAD. It involves establishing a graft from another vessel of the body to bypass the narrowed coronary artery and restore blood flow to the cardiac muscle (Urden, Stacy, & Lough, 2017). Even though Coronary Artery Bypass Graft surgery is believed to provide more complete revascularization and leading to improved long term outcomes than PCI (Hillis et al., 2011); the recovery process after hospital discharge might be complicated by the occurrence of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) (Goldfarb et al., 2015). Major Adverse Cardiovascular and Cerebrovascular Events consist of mortality, myocardial infarction (MI), stroke and need for repeat revascularization (Goldfarb et al., 2015). Mortality leads to losing the patient after a major and costly surgery, while; MI, stroke and need for reopening or repeat revascularization leads to patient readmission to the hospital and might end up with increased mortality rate (Goldfarb et al., 2015; Hillis et al., 2011). Mortality rate after CABG ranges from 1.1% -24 % (Grundeken et al., 2013; Jose et al., 2019; Shah et al., 2019; Wrobel et al., 2015). Among the Jordanian CABG population; all-cause mortality reported 30 day after surgery was 5.9 % in 1046 patients (AlWaqfi, Khader, & Ibrahim, 2012). The readmission rate of CABG patients within 30 days is seriously high (Feng, White, Gaber-Baylis, Turnbull, & Rong, 2018). More specifically; Feng et al., (2018) reported that 28601 adult CABG patients out of 177229 (16 %) in the united States (US) were readmitted within 30 days (Feng et al., 2018). Another study revealed that more than 60 % of CABG patients readmissions occur within the first week post discharge (Price, Romeiser, Gnerre, Shroyer, & Rosengart, 2013). Several reasons stand behind hospital readmissions after CABG surgery (Mary, 2017; Seifert, 2017). Price et al., (2013) reported that 25% of 13% hospital readmissions after CABG surgery were attributed to cardiac reasons. Myocardial Infarction after CABG surgery is Type 5 MI (Thygesen et al., 2018). Shah et al., (2016) reported that out of 2215 CABG patients 5.8 % developed acute MI post-surgery while 3.8 % required repeat revascularization. Repeat revascularization is a new CABG or PCI procedure needs to be done due to documented ischemia or graft failure and it is one of the MACCE that might occur within 30 days after CABG surgery (Takagi et al., 2013). The incidence rate of repeated revascularization among CABG patient is ranging from 0.5 % -1.3 % (Deppe et al., 2016; Taggart et al., 2015; Wu et al., 2015) Stroke is an acute focal neurological deficit lasting ≥ 24 hours with or without confirmatory imaging (Goldfarb et al., 2015). Around 1.3% of CABG patients developed stroke after the surgery which causes near 20 % mortality rate perioperative (Gaudino et al., 2019). Among Jordanian population; CABG Patients who had stroke were 2.3 % of the sample (1046 patients). Of these; 33.3 % were died (AlWaqfi et al., 2012). Reducing mortality and hospital readmission following cardiac surgery has become a national priority in the US and worldwide. Unclear discharge instructions and lack of follow up plans are among the reported reasons for hospital readmissions (Amoah & Mwanri, 2016). Patient experience with discharge instructions show that patients who discharged with sufficient information and provided follow-up care were better in managing postoperative problems and experienced improved post discharge outcomes (M. Akbari & Celik, 2015). Therefore; have a better health-related quality of life (HRQOL). The current study intervention is a nurse led discharge program based on the Re-Engineered Discharge program (Project-RED) ( Agency of Healthcare Research and Quality [AHRQ], 2013) which is a package of services designed to minimize discharge failures and minimize readmissions (Jack et al., 2009; S. Mitchell, Weigel, Laurens, Martin, & Jack, 2017; S. E. Mitchell et al., 2016; Patel & Dickerson, 2018), reduce mortality, morbidity, complication (Ceppa et al., 2015) and improve patients outcomes (Adams, Stephens, Whiteman, Kersteen, & Katruska, 2014; Berkowitz et al., 2013; Cancino et al., 2017) . Project-RED aims to reduce hospital readmissions through a series of structured steps led by a nurse called discharge advocate. (Jack et al., 2009)


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 174
Est. completion date June 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Adult patient aged 21 years or older - Underwent first time isolated elective CABG surgery for single, double, or triple CAD. - Patient speak and read Arabic to eliminate any barriers of communication during the process of discharge and telephone call - Patient who has contact telephone number - Doesn't have Aortic calcification, and /or previous stroke - Welling to participate and Able to provide informed consent Exclusion Criteria: - Adult patient aged 21 years or older - Underwent first time isolated elective CABG surgery for single, double, or triple CAD. - Patient speak and read Arabic to eliminate any barriers of communication during the process of discharge and telephone call - Patient who has contact telephone number - Doesn't have Aortic calcification, and /or previous stroke - Welling to participate and Able to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nurse led discharge planning program
a discharge planning program. It is a modified discharge planning program depends basically on the Re-Engineered Discharge program which is a program developed by Boston Medical Center in collaboration with AHRQ , 2013. The intervention consists of several components. The program components include making appointments for follow-up care (e.g., medical appointments and post discharge tests/labs). Plan for the follow-up of results from tests or labs that are pending at discharge. Identify the correct medicines and a plan for the patient to obtain them. Teach a written discharge plan the patient can understand. Educate the patient about his or her diagnosis and medicines. Review with the patient what to do if a problem arises. Assess the degree of the patient's understanding of the discharge plan and provide a telephone reinforcement of the discharge plan

Locations

Country Name City State
Jordan University of Jordan Amman

Sponsors (2)

Lead Sponsor Collaborator
University of Jordan Jordanian Royal Medical Services

Country where clinical trial is conducted

Jordan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major adverse cardiovascular and cerebrovascular events The variable of MACCE includes MI, Stroke, and all-cause death and repeat re-vascularization 30 days
Secondary Adherence to medications Adherence to medications 3 months
See also
  Status Clinical Trial Phase
Completed NCT00248885 - Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG) N/A
Completed NCT04473287 - The Effect of Reflexology After Coronary Artery Bypass Graft Surgery N/A
Completed NCT03892460 - Transitional Rehabilitation in CABG Patients N/A
Completed NCT04238806 - Desflurane,Brain Natriuretic Peptide and Cardiac Surgery N/A
Terminated NCT01246011 - Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion Phase 4
Completed NCT00402506 - A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Phase 3
Recruiting NCT03900026 - Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery Phase 4
Completed NCT01095419 - Effects of Massage Therapy on Sleep After Heart Surgery N/A
Recruiting NCT05377983 - The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft N/A
Completed NCT03123107 - Vitamin C in Cardiac Surgery Patients Phase 1
Terminated NCT00735722 - A(f)MAZE-CABG Study N/A
Recruiting NCT04652375 - Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures N/A
Completed NCT05830682 - Effect of Using Walking Aid on Mobility N/A
Completed NCT05191745 - Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery Phase 3
Enrolling by invitation NCT01127802 - Changes of Functional Status, Symptoms Distress and Quality of Life in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery N/A
Active, not recruiting NCT00396760 - Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery Phase 3
Completed NCT04111744 - Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery N/A
Active, not recruiting NCT01063491 - Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study Phase 3
Completed NCT00618592 - Does Pre-operative Carbohydrate Loading Reduce Insulin Resistance and Improve Outcomes in Elective Surgical Patients? N/A
Withdrawn NCT04717817 - Inspiratory Muscle Training Prior to Conventional and Minimal Invasive Heart Surgery N/A